![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Single-Tablet Regimen of Ledipasvir/Sofosbuvir for 12 Weeks in HCV Genotype 1- or 4-Infected Patients With HIV-1 Coinfection: the Phase 3 ION-4 Study
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Curtis Cooper,1 Susanna Naggie,2 Michael Saag,3 Jenny Yang,4 Luisa Stamm,4 Philip Pang,4 John McHutchison,4 Douglas Dieterich,5 Mark Sulkowski6
1Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; 2Duke Clinical Research Institute, Durham, North Carolina, USA; 3The University of Alabama at Birmingham School of Medicine, Alabama, USA; 4Gilead Sciences, Inc., Foster City, California, USA; 5The Mount Sinai Hospital, New York, New York, USA; 6Johns Hopkins Medicine, Baltimore, Maryland, USA
![EASL1.gif](../images/042815/042815-7/EASL1.gif)
![EASL2.gif](../images/042815/042815-7/EASL2.gif)
![EASL3.gif](../images/042815/042815-7/EASL3.gif)
![EASL4.gif](../images/042815/042815-7/EASL4.gif)
![EASL5.gif](../images/042815/042815-7/EASL5.gif)
![EASL6.gif](../images/042815/042815-7/EASL6.gif)
![EASL7.gif](../images/042815/042815-7/EASL7.gif)
![EASL8.gif](../images/042815/042815-7/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|